# NOSTRIN

## Overview
NOSTRIN is a gene that encodes the nitric oxide synthase trafficking protein, which is a crucial adaptor protein involved in the regulation of endothelial nitric oxide synthase (eNOS) activity and localization. This protein is categorized as a member of the PCH family and is characterized by its ability to form homotrimers, facilitating interactions with multiple binding partners. NOSTRIN plays a significant role in the internalization and intracellular trafficking of eNOS, which is essential for nitric oxide (NO) production, a key factor in vascular function and health. The protein's interactions with other proteins, such as dynamin, N-WASP, and caveolin-1, are mediated through its SH3 domain and are vital for its function in endothelial cells (Icking2005NOSTRIN; Schilling2006Translocation). NOSTRIN's involvement in various cellular processes underscores its importance in maintaining cardiovascular health and its potential implications in diseases such as cancer and liver disorders (Mookerjee2007Increased; Chakraborty2017Nitricoxide).

## Structure
NOSTRIN is a protein characterized by several distinct domains that contribute to its function and localization. It belongs to the PCH family of proteins and contains an N-terminal Fes/CIP4 homology (FCH) domain, a C-terminal SH3 domain, and one or two coiled-coil domains (Icking2005NOSTRIN; Icking2005FCHCdc15). The FCH domain is crucial for membrane association, while the SH3 domain mediates interactions with proteins such as dynamin and N-WASP (Icking2005NOSTRIN; Icking2005FCHCdc15). NOSTRIN also contains an HR1 motif, a Rho GTPase-interacting module, although its function is not fully understood (Icking2005NOSTRIN).

The protein forms homotrimers, indicating a quaternary structure, which facilitates interactions with multiple binding partners (Icking2005NOSTRIN). The region spanning amino acids 250-434, which includes a coiled-coil domain, is essential for oligomerization (Icking2005NOSTRIN). NOSTRIN interacts with endothelial nitric oxide synthase (eNOS) and is involved in its internalization, forming complexes with eNOS, dynamin, and N-WASP (Icking2005NOSTRIN; Schilling2006Translocation). The protein is evolutionarily conserved across species, with significant sequence identity in rat, mouse, D. melanogaster, and C. elegans (Icking2005NOSTRIN).

## Function
NOSTRIN (nitric oxide synthase trafficking) is a protein that plays a critical role in the regulation of endothelial nitric oxide synthase (eNOS) activity and localization in endothelial cells. It functions as a homotrimeric adaptor protein, facilitating the internalization and intracellular trafficking of eNOS, which is crucial for nitric oxide (NO) production, a key factor in vascular function and health (Icking2005NOSTRIN). NOSTRIN interacts with eNOS via its SH3 domain, forming complexes with other proteins such as dynamin and N-WASP, which are involved in endocytosis and actin polymerization (Icking2005NOSTRIN).

NOSTRIN's role extends to the regulation of eNOS activity by influencing its subcellular localization, often translocating eNOS away from the plasma membrane to intracellular vesicular structures (Schilling2006Translocation). This translocation is mediated through interactions with caveolin-1, forming a ternary complex that modulates eNOS activity and availability (Schilling2006Translocation). The absence of NOSTRIN leads to impaired eNOS activity, reduced NO production, and subsequent cardiovascular dysfunction, such as elevated blood pressure and diastolic heart dysfunction (Kovacevic2015The). Through these mechanisms, NOSTRIN is essential for maintaining vascular tone and cardiovascular health.

## Clinical Significance
Alterations in the expression or function of the NOSTRIN gene have been implicated in several diseases. In the context of cancer, NOSTRIN acts as an endogenous tumor suppressor by down-regulating NFκB and Akt signaling pathways, which are crucial for cell proliferation, invasion, and angiogenesis. Elevated levels of NOSTRIN in cancer patients are associated with increased survival rates, suggesting its potential as a prognostic marker (Chakraborty2017Nitricoxide).

In cardiovascular diseases, NOSTRIN is essential for nitric oxide (NO) production, which is crucial for vasodilation and blood pressure regulation. Mice with endothelial cell-specific deletion of NOSTRIN exhibit impaired NO production, leading to increased blood pressure and diastolic heart dysfunction (Kovacevic2015The). NOSTRIN's interaction with the muscarinic M3 receptor is necessary for proper vascular function, and its absence results in impaired acetylcholine-induced relaxation of arteries (Kovacevic2015The).

In the context of liver diseases, increased NOSTRIN expression is observed in patients with alcoholic hepatitis and cirrhosis, correlating with reduced endothelial nitric oxide synthase (eNOS) activity and higher portal pressures. This suggests a role in the pathophysiology of portal hypertension and hepatic inflammation (Mookerjee2007Increased). 

NOSTRIN also plays a role in kidney function, where its knockdown in zebrafish leads to proteinuria and compromised glomerular barrier function, indicating its importance in maintaining renal health (Kirsch2013Knockdown).

## Interactions
NOSTRIN interacts with several proteins, playing a crucial role in endothelial cell function and nitric oxide synthase (NOS) regulation. It forms a ternary complex with endothelial nitric oxide synthase (eNOS) and caveolin-1, which is essential for the translocation of eNOS from the plasma membrane to intracellular structures. This interaction is mediated by the central region of NOSTRIN and does not require its SH3 domain (Schilling2006Translocation). 

NOSTRIN also interacts with dynamin and N-WASP, facilitating the internalization of eNOS. These interactions occur through the SH3 domain of NOSTRIN, which is necessary for binding to these proteins (Icking2005NOSTRIN). The protein's ability to oligomerize into homotrimers is crucial for these interactions, allowing NOSTRIN to function as a multivalent adaptor protein (Icking2005NOSTRIN).

Additionally, NOSTRIN interacts with TNF receptor associated factor 6 (TRAF6), leading to the suppression of NFκB activity and inhibition of Akt activation. This interaction is also mediated by the SH3 domain of NOSTRIN (Chakraborty2017Nitricoxide). These interactions highlight NOSTRIN's role in modulating endothelial cell signaling pathways and its potential impact on cardiovascular function.


## References


[1. (Icking2005NOSTRIN) Ann Icking, Simone Matt, Nils Opitz, Anja Wiesenthal, Werner Müller-Esterl, and Kirstin Schilling. Nostrin functions as a homotrimeric adaptor protein facilitating internalization of enos. Journal of Cell Science, 118(21):5059–5069, November 2005. URL: http://dx.doi.org/10.1242/jcs.02620, doi:10.1242/jcs.02620. This article has 57 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.02620)

[2. (Mookerjee2007Increased) Rajeshwar P. Mookerjee, Anja Wiesenthal, Ann Icking, Stephen J. Hodges, Nathan A. Davies, Kirstin Schilling, Sambit Sen, Roger Williams, Marco Novelli, Werner Müller-Esterl, and Rajiv Jalan. Increased gene and protein expression of the novel enos regulatory protein nostrin and a variant in alcoholic hepatitis. Gastroenterology, 132(7):2533–2541, June 2007. URL: http://dx.doi.org/10.1053/J.GASTRO.2006.12.035, doi:10.1053/j.gastro.2006.12.035. This article has 72 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1053/J.GASTRO.2006.12.035)

[3. (Kovacevic2015The) Igor Kovacevic, Miriam Müller, Baktybek Kojonazarov, Alexander Ehrke, Voahanginirina Randriamboavonjy, Karin Kohlstedt, Tanja Hindemith, Ralph Theo Schermuly, Ingrid Fleming, Meike Hoffmeister, and Stefanie Oess. The f-bar protein nostrin dictates the localization of the muscarinic m3 receptor and regulates cardiovascular function. Circulation Research, 117(5):460–469, August 2015. URL: http://dx.doi.org/10.1161/CIRCRESAHA.115.306187, doi:10.1161/circresaha.115.306187. This article has 22 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1161/CIRCRESAHA.115.306187)

[4. (Kirsch2013Knockdown) Torsten Kirsch, Jessica Kaufeld, Ron Korstanje, Dirk M. Hentschel, Lynne Staggs, Frank Bollig, Michaela Beese, Patricia Schroder, Lisa Boehme, Hermann Haller, and Mario Schiffer. Knockdown of the hypertension-associated gene nostrin alters glomerular barrier function in zebrafish ( danio rerio ). Hypertension, 62(4):726–730, October 2013. URL: http://dx.doi.org/10.1161/hypertensionaha.113.01882, doi:10.1161/hypertensionaha.113.01882. This article has 10 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1161/hypertensionaha.113.01882)

[5. (Icking2005FCHCdc15) Ann Icking, Kirstin Schilling, Anja Wiesenthal, Nils Opitz, and Werner Müller-Esterl. Fch/cdc15 domain determines distinct subcellular localization of nostrin. FEBS Letters, 580(1):223–228, December 2005. URL: http://dx.doi.org/10.1016/j.febslet.2005.11.078, doi:10.1016/j.febslet.2005.11.078. This article has 17 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2005.11.078)

[6. (Schilling2006Translocation) Kirstin Schilling, Nils Opitz, Anja Wiesenthal, Stefanie Oess, Ritva Tikkanen, Werner Müller-Esterl, and Ann Icking. Translocation of endothelial nitric-oxide synthase involves a ternary complex with caveolin-1 and nostrin. Molecular Biology of the Cell, 17(9):3870–3880, September 2006. URL: http://dx.doi.org/10.1091/mbc.e05-08-0709, doi:10.1091/mbc.e05-08-0709. This article has 59 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e05-08-0709)

[7. (Chakraborty2017Nitricoxide) Shreeta Chakraborty and Rupasri Ain. Nitric-oxide synthase trafficking inducer is a pleiotropic regulator of endothelial cell function and signaling. Journal of Biological Chemistry, 292(16):6600–6620, April 2017. URL: http://dx.doi.org/10.1074/jbc.m116.742627, doi:10.1074/jbc.m116.742627. This article has 44 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1074/jbc.m116.742627)